Colon cancer is one of the most common forms of cancer in Germany. Prof. Dr. med. Sebastian Zeißig, group leader at the DFG Research Center for Regenerative Therapies Dresden (CRTD) - Cluster of Excellence at the TU Dresden and physician at the Department of Medicine I, University Hospital Carl Gustav Carus Dresden, has now shown a decisive role of gut bacteria in the regulation of intestinal stem cells and the development of colon cancer. This discovery promises new therapies not only for cancer but for promoting regeneration of the intestine, for example after chemotherapy.
The intestinal surface is a rapidly renewing tissue, whose regeneration is driven by stem cells. Damage of these intestinal stem cells, as observed upon chemotherapy, leads to impaired regeneration of the intestine and severe illness.
Prof. Dr. med. Sebastian Zeißig
On the other hand, genetic mutations that further promote the growth of intestinal stem cells are associated with uncontrolled organ regeneration and the development of colon cancer. Tight control of intestinal stem cells is therefore required to allow for regeneration but to prevent cancer.
Sebastian Zeißig’s group has now demonstrated that bacteria within the normal gut microbiota can invade the intestinal tissue and activate an enzyme in stem cells that facilitates stem cell growth and cancer development. This discovery could form the basis of novel therapies for the prevention and treatment of colon cancer.
“In the future, bacteria engineered to block these pathways could potentially be used as probiotics which act in local manner in the intestine to inhibit the growth of colon cancer and to perhaps even prevent its development”, says Sebastian Zeißig.
Since stem cells are also critical for regeneration in the intestine, therapies that target these pathways may further help to design new drugs that reduce side effects associated with chemotherapy, radiotherapy or other causes of intestinal damage.
With his research group at the CRTD, Zeißig has already started to engineer intestinal bacteria with the goal of influencing regeneration and cancer development in the intestine. Zeißig, who is also a practicing physician at the Department of Medicine I, University Hospital Carl Gustav Carus Dresden, adds “With its focus on stem cell biology and a close link to clinical medicine, the CRTD indeed offers a unique environment for physician scientists to develop new treatments for regenerative medicine and cancer therapy.”
"Epithelial calcineurin in the control of microbiota-dependent intestinal tumor development" (NMED-A75820A)
Phone: +49 351 458 82065, e-Mail: firstname.lastname@example.org
Franziska Clauß | idw - Informationsdienst Wissenschaft
New way to look at cell membranes could change the way we study disease
19.11.2018 | University of Oxford
Controlling organ growth with light
19.11.2018 | European Molecular Biology Laboratory
Researchers at the University of New Hampshire have captured a difficult-to-view singular event involving "magnetic reconnection"--the process by which sparse particles and energy around Earth collide producing a quick but mighty explosion--in the Earth's magnetotail, the magnetic environment that trails behind the planet.
Magnetic reconnection has remained a bit of a mystery to scientists. They know it exists and have documented the effects that the energy explosions can...
Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.
Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
19.11.2018 | Event News
09.11.2018 | Event News
06.11.2018 | Event News
19.11.2018 | Materials Sciences
19.11.2018 | Information Technology
19.11.2018 | Life Sciences